Spectral AI, based in Dallas, Texas, develops the DeepView® system, a diagnostic device and predictive software for wound and burn assessment. The DeepView® platform uses multispectral imaging and AI algorithms to provide rapid, objective wound healing assessments, replacing subjective clinician judgment and reducing decision time from weeks to a single day. Clinical studies show DeepView® achieves much higher accuracy than standard care. The system is non-invasive, radiation-free, and does not ....
09 Feb 2026
Spectral AI, Inc. (MDAI.NQ): Pivotal year ahead as DeepView awaits FDA approval and commercial launch
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Spectral AI, Inc. (MDAI.NQ): Pivotal year ahead as DeepView awaits FDA approval and commercial launch
Spectral AI, Inc. Class A (MDAI:NAS) | 0 0 0.0%
- Published:
09 Feb 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
10 -
Spectral AI, based in Dallas, Texas, develops the DeepView® system, a diagnostic device and predictive software for wound and burn assessment. The DeepView® platform uses multispectral imaging and AI algorithms to provide rapid, objective wound healing assessments, replacing subjective clinician judgment and reducing decision time from weeks to a single day. Clinical studies show DeepView® achieves much higher accuracy than standard care. The system is non-invasive, radiation-free, and does not ....